In vivo hepatic reprogramming of myofibroblasts with AAV vectors as a therapeutic strategy for liver fibrosis
Liver fibrosis, a form of scarring, gradually develops in chronic liver diseases when hepatocyte regeneration cannot compensate for hepatocyte death. At earlier stages, collagen produced by activated myofibroblasts (MFs) functions to maintain tissue integrity, but upon repeated injury, collagen accu...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2016
|
| In: |
Cell stem cell
Year: 2016, Jahrgang: 18, Heft: 6, Pages: 809-816 |
| ISSN: | 1875-9777 |
| DOI: | 10.1016/j.stem.2016.05.005 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.stem.2016.05.005 Verlag, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325707/ |
| Verfasserangaben: | Milad Rezvani, Regina Español-Suñer, Yann Malato, Laure Dumont, Andrew A. Grimm, Eike Kienle, Julia G. Bindman, Ellen Wiedtke, Bernadette Y. Hsu, Syed J. Naqvi, Robert F. Schwabe, Carlos U. Corvera, Dirk Grimm, and Holger Willenbring |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1586848801 | ||
| 003 | DE-627 | ||
| 005 | 20230427034223.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190131s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.stem.2016.05.005 |2 doi | |
| 035 | |a (DE-627)1586848801 | ||
| 035 | |a (DE-576)516848801 | ||
| 035 | |a (DE-599)BSZ516848801 | ||
| 035 | |a (OCoLC)1341034953 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Rezvani, Milad |e VerfasserIn |0 (DE-588)1037029798 |0 (DE-627)751881791 |0 (DE-576)391034936 |4 aut | |
| 245 | 1 | 0 | |a In vivo hepatic reprogramming of myofibroblasts with AAV vectors as a therapeutic strategy for liver fibrosis |c Milad Rezvani, Regina Español-Suñer, Yann Malato, Laure Dumont, Andrew A. Grimm, Eike Kienle, Julia G. Bindman, Ellen Wiedtke, Bernadette Y. Hsu, Syed J. Naqvi, Robert F. Schwabe, Carlos U. Corvera, Dirk Grimm, and Holger Willenbring |
| 264 | 1 | |c 2016 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 31.01.2019 | ||
| 520 | |a Liver fibrosis, a form of scarring, gradually develops in chronic liver diseases when hepatocyte regeneration cannot compensate for hepatocyte death. At earlier stages, collagen produced by activated myofibroblasts (MFs) functions to maintain tissue integrity, but upon repeated injury, collagen accumulation suppresses hepatocyte regeneration, ultimately leading to liver failure. As a strategy to generate new hepatocytes and limit collagen deposition in the chronically injured liver, we developed in vivo reprogramming of MFs into hepatocytes using adeno-associated virus (AAV) vectors expressing hepatic transcription factors. We first identified the AAV6 subtype as effective in transducing MFs in mouse models of chronic liver disease. We then use lineage-tracing approaches to show that hepatocytes reprogrammed from MFs replicate primary hepatocyte function, and that liver fibrosis in AAV treated animals is reduced. Because AAV vectors are already used for liver-directed human gene therapy, our strategy has potential for clinical translation into a therapy for liver fibrosis. | ||
| 700 | 1 | |a Wiedtke, Ellen |e VerfasserIn |0 (DE-588)1071738372 |0 (DE-627)826301347 |0 (DE-576)433285206 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell stem cell |d Amsterdam [u.a.] : Elsevier, 2007 |g 18(2016), 6, Seite 809-816 |h Online-Ressource |w (DE-627)535183836 |w (DE-600)2375356-0 |w (DE-576)267378114 |x 1875-9777 |7 nnas |a In vivo hepatic reprogramming of myofibroblasts with AAV vectors as a therapeutic strategy for liver fibrosis |
| 773 | 1 | 8 | |g volume:18 |g year:2016 |g number:6 |g pages:809-816 |g extent:8 |a In vivo hepatic reprogramming of myofibroblasts with AAV vectors as a therapeutic strategy for liver fibrosis |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.stem.2016.05.005 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325707/ |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190131 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1071738372 |a Wiedtke, Ellen |m 1071738372:Wiedtke, Ellen |d 700000 |d 716000 |d 700000 |d 718000 |e 700000PW1071738372 |e 716000PW1071738372 |e 700000PW1071738372 |e 718000PW1071738372 |k 0/700000/ |k 1/700000/716000/ |k 0/700000/ |k 1/700000/718000/ |p 8 | ||
| 999 | |a KXP-PPN1586848801 |e 305120949X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Rezvani","given":"Milad","display":"Rezvani, Milad","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Wiedtke, Ellen","roleDisplay":"VerfasserIn","role":"aut","family":"Wiedtke","given":"Ellen"}],"title":[{"title_sort":"In vivo hepatic reprogramming of myofibroblasts with AAV vectors as a therapeutic strategy for liver fibrosis","title":"In vivo hepatic reprogramming of myofibroblasts with AAV vectors as a therapeutic strategy for liver fibrosis"}],"recId":"1586848801","language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 31.01.2019"],"name":{"displayForm":["Milad Rezvani, Regina Español-Suñer, Yann Malato, Laure Dumont, Andrew A. Grimm, Eike Kienle, Julia G. Bindman, Ellen Wiedtke, Bernadette Y. Hsu, Syed J. Naqvi, Robert F. Schwabe, Carlos U. Corvera, Dirk Grimm, and Holger Willenbring"]},"id":{"eki":["1586848801"],"doi":["10.1016/j.stem.2016.05.005"]},"origin":[{"dateIssuedDisp":"2016","dateIssuedKey":"2016"}],"relHost":[{"disp":"In vivo hepatic reprogramming of myofibroblasts with AAV vectors as a therapeutic strategy for liver fibrosisCell stem cell","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 19.09.12"],"language":["eng"],"recId":"535183836","pubHistory":["1.2007 -"],"titleAlt":[{"title":"Cell / Stem cell"}],"part":{"volume":"18","text":"18(2016), 6, Seite 809-816","extent":"8","year":"2016","pages":"809-816","issue":"6"},"title":[{"title":"Cell stem cell","title_sort":"Cell stem cell"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"2007-","dateIssuedKey":"2007","publisher":"Elsevier"}],"id":{"issn":["1875-9777"],"zdb":["2375356-0"],"eki":["535183836"]}}],"physDesc":[{"extent":"8 S."}]} | ||
| SRT | |a REZVANIMILINVIVOHEPA2016 | ||